Vaughn James J 4
4 · GENOMIC HEALTH INC · Filed Oct 9, 2019
Insider Transaction Report
Form 4
Vaughn James J
Chief Commercial Officer
Transactions
- Sale
Common Stock
2019-10-08$67.75/sh−4,500$304,875→ 16,417 total - Exercise/Conversion
Employee Stock Option (right to buy) Holding
2019-10-08−4,500→ 39,707 totalExercise: $33.21Exp: 2028-01-31→ Common Stock (4,500 underlying) - Exercise/Conversion
Common Stock
2019-10-08$33.21/sh+4,500$149,445→ 20,917 total
Footnotes (5)
- [F1]Includes an aggregate of 11,281 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- [F2]These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 11, 2019.
- [F3]Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- [F4]Represents weighted average sale price. Actual sale prices ranged from $67.46 to $68.29.
- [F5]The option became exercisable as to 25% of the shares on January 31, 2019, and becomes exercisable as to 1/48th of the shares each full month thereafter.